Ribonucleotide reductase is a rate-limiting enzyme in DNA synthesis and is
composed of two different proteins, R1 and R2. The R2 protein appears to be
rate-limiting for enzyme activity in proliferating cells, and it is phosph
orylated by p34(cdc2) and CDK2, mediators of cell cycle transition events.
A sequence in the R2 protein at serine-20 matches a consensus sequence for
p34(cdc2) and CDK2 kinases. We tested the hypothesis that the serine-20 res
idue was the major p34(cdc2) kinase site of phosphorylation. Three peptides
were synthesized (from Asp-13 to Ala-28) that contained either the wild ty
pe amino acid sequence(Asp-Gln-Gln-Gln-Leu-Gln-Leu-Ser-Pro-Leu-Lys-Arg-Leu-
Thr-Leu-Ala, serine peptide) or a mutation, in which the serine residue was
replaced with an alanine residue (alanine peptide) or a threonine residue
(threonine peptide). Only the serine peptide and threonine peptide were pho
sphorylated by p34(cdc2) kinase. In two-dimensional phosphopeptide mapping
experiments of serine peptide and Asp-N endoproteinase digested R2 protein,
peptide co-migration patterns suggested that the synthetic phosphopeptide
containing serine-20 was identical to the major Asp-N digested R2 phosphope
ptide. To further test the hypothesis that serine-20 is the primary phospho
rylated residue on R2 protein, three recombinant R2 proteins (R2-Thr, R2-As
p and R2-Ala) were generated by site-directed mutagenesis, in which the ser
ine-20 residue was replaced with threonine, aspartic acid or alanine residu
es. Wild type R2 and threonine-substituted R2 proteins (R2-Thr) were phosph
orylated by p34(cdc2) kinase, whereas under the same experimental condition
s, R2-Asp and R2-Ala phosphorylation was not detected. Furthermore, the pho
sphorylated amino acid residue in the R2-Thr protein was determined to be p
hosphothreonine. Therefore, by replacing a serine-20 residue with a threoni
ne, the phosphorylated amino acid in R2 protein was changed to a phosphothr
eonine. In total, these results firmly establish that a major p34(cdc2) pho
sphorylation site on the ribonucleotide reductase R2 protein occurs near th
e N-terminal end at serine-20, which is found within the sequence Ser-Pro-L
eu-Lys-Arg-Leu. Comparison of ribonucleotide reductase activities between w
ild type and mutated forms of the R2 proteins suggested that mutation at se
rine-20 did not significantly affect enzyme activity. (C) 1999 Elsevier Sci
ence B.V. All rights reserved.